首页> 外文期刊>Dementia and Geriatric Cognitive Disorders Extra >Alzheimer’s Disease with Vascular Component: A Distinct Clinical Entity
【24h】

Alzheimer’s Disease with Vascular Component: A Distinct Clinical Entity

机译:阿尔茨海默氏病与血管成分:不同的临床实体

获取原文
       

摘要

Background: Longitudinal reports on the clinical features of patients with Alzheimer’s disease (AD) and concomitant cerebrovascular disease are scarce. Methods: We elaborated a working definition of AD with vascular component (ADVC), and this definition was retrospectively investigated in a cohort of patients with cognitive deterioration who were prescribed a cholinesterase inhibitor during usual practice. Results: A total of 137 patients with probable AD and 66 patients with ADVC were studied during a mean follow-up period of 2.8 years. Univariate analyses demonstrated worse functional evolution and anticipation of psychotic symptoms and agitation in the ADVC group. Conclusions: The present results are consistent with an additive model of predominantly frontal-subcortical vascular damage in AD.
机译:背景:关于阿尔茨海默氏病(AD)和伴发性脑血管疾病的临床特征的纵向报道很少。方法:我们详细阐述了具有血管成分(ADVC)的AD的有效定义,并对这一定义进行了回顾性研究,该研究针对一组认知功能恶化的患者,这些患者在常规实践中已开具胆碱酯酶抑制剂。结果:在平均2.8年的随访期内,共研究了137位可能的AD患者和66位ADVC患者。单因素分析表明,ADVC组的功能发展较差,对精神病症状和躁动的预期更高。结论:本研究结果与AD中主要为额叶皮层下血管损伤的累加模型一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号